Apnimed (APMD) vs Helus Pharma (HELP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Helus Pharma is the larger company by market cap ($767.9 million vs $751.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APMD | HELP |
|---|---|---|
| Share price | $18.04 | $10.51 |
| Market cap | $751.02M | $767.86M |
| 1-day change | -3.27% | -2.32% |
| YTD return | — | +28.48% |
| 1-year return | — | +73.15% |
| 5-year return | — | -85.96% |
| P/E ratio (TTM) | 2.50 | — |
| EPS (TTM) | $7.22 | $-4.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $35.29 | $15.15 |
| 52-week low | $16.12 | $3.76 |
| Distance from 52-week high | -48.88% | -30.63% |
| Average volume | 558.59K | 1.79M |
| Shares outstanding | 41.63M | 73.06M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
APMD vs HELP FAQ
Which is bigger, Apnimed or Helus Pharma?
Helus Pharma (HELP) is larger, with a market capitalization of $767.86M compared with $751.02M for Apnimed (APMD).
Are Apnimed and Helus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.